{"url_path":"/sec/pom/10-k/2026/item-14","section_key":"item-14","section_title":"Item 14 MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1877971/0001213900-26-056576-index.html","accession_number":"0001213900-26-056576","cik":"0001877971","ticker":"POM","issuer_name":"POMDOCTOR Ltd","edgar_url":"https://www.sec.gov/Archives/edgar/data/1877971/0001213900-26-056576-index.html","primary_entity_key":"0001877971","primary_entity_name":"POMDOCTOR Ltd"},"word_count":361,"has_tables":true,"body_markdown":"ITEM 14.MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS\n\n** **\n\n**14.A. – 14.D. Material Modifications to\nthe Rights of Security Holders**\n\n \n\nSee “Item 10. Additional\nInformation” for a description of the rights of shareholders, which remain unchanged.\n\n** **\n\n**14.E. Use of Proceeds**\n\n \n\nThe following “Use\nof Proceeds” information relates to the registration statement on Form F-1 (File No. 333-285771), as amended, for our initial public\noffering, which registered 833,334 Class A ordinary shares represented by 5,000,004 ADSs issued and sold by us, and the underwriters’\nexercise of their option to purchase from us 750,000 additional ADSs representing 125,000 Class A ordinary shares, at a public offering\nprice of US$4.00 per ADS. The registration statement was declared effective by the SEC on September 30, 2025, for our initial public\noffering, which closed in October 2025. Joseph Stone Capital was the representative of the underwriters.\n\n \n\nWe received net proceeds\nof US$20.0 million from our initial public offering and the underwriters’ exercise of over-allotment option. Our expenses incurred\nand paid to others in connection with the issuance and distribution of the ADSs in our offering totaled US$2.6 million, which included\nUS$1.7 million for underwriting discounts and commissions and US$0.8 million for other expenses. None of the transaction expenses included\npayments to directors or officers of our company or their associates, persons owning 10% or more of our equity securities or our affiliates.\nNone of the net proceeds we received from the initial public offering were paid, directly or indirectly, to any of our directors or officers\nor their associates, persons owning 10% or more of our equity securities or our affiliates.\n\n \n\nFor the period from the date\nthat the registration statement on Form F-1 was declared effective by the SEC to December 31, 2025, we used approximately US$3.4 million\nof the net proceeds from our initial public offering for operating expenses, working capital, capital expenditures and other general corporate\npurposes. There is no material change in the use of proceeds as described in the registration statement. We still intend to use the remainder\nof the proceeds from our initial public offering for purposes as disclosed in our registration statement on Form F-1."}